1. Home
  2. RLMD vs PPIH Comparison

RLMD vs PPIH Comparison

Compare RLMD & PPIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • PPIH
  • Stock Information
  • Founded
  • RLMD 2004
  • PPIH 1993
  • Country
  • RLMD United States
  • PPIH United States
  • Employees
  • RLMD N/A
  • PPIH N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • PPIH Pollution Control Equipment
  • Sector
  • RLMD Health Care
  • PPIH Industrials
  • Exchange
  • RLMD Nasdaq
  • PPIH Nasdaq
  • Market Cap
  • RLMD 110.6M
  • PPIH 110.6M
  • IPO Year
  • RLMD N/A
  • PPIH N/A
  • Fundamental
  • Price
  • RLMD $2.75
  • PPIH $15.40
  • Analyst Decision
  • RLMD Hold
  • PPIH
  • Analyst Count
  • RLMD 2
  • PPIH 0
  • Target Price
  • RLMD $7.50
  • PPIH N/A
  • AVG Volume (30 Days)
  • RLMD 126.6K
  • PPIH 49.7K
  • Earning Date
  • RLMD 11-07-2024
  • PPIH 12-06-2024
  • Dividend Yield
  • RLMD N/A
  • PPIH N/A
  • EPS Growth
  • RLMD N/A
  • PPIH 214.84
  • EPS
  • RLMD N/A
  • PPIH 1.90
  • Revenue
  • RLMD N/A
  • PPIH $157,704,000.00
  • Revenue This Year
  • RLMD N/A
  • PPIH N/A
  • Revenue Next Year
  • RLMD N/A
  • PPIH N/A
  • P/E Ratio
  • RLMD N/A
  • PPIH $8.31
  • Revenue Growth
  • RLMD N/A
  • PPIH 13.34
  • 52 Week Low
  • RLMD $1.88
  • PPIH $6.33
  • 52 Week High
  • RLMD $7.22
  • PPIH $16.32
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 23.58
  • PPIH 63.89
  • Support Level
  • RLMD $2.96
  • PPIH $13.50
  • Resistance Level
  • RLMD $3.43
  • PPIH $15.38
  • Average True Range (ATR)
  • RLMD 0.21
  • PPIH 0.82
  • MACD
  • RLMD -0.07
  • PPIH 0.08
  • Stochastic Oscillator
  • RLMD 1.60
  • PPIH 74.01

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About PPIH Perma-Pipe International Holdings Inc.

Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in the reportable segment of Piping Systems. The company engineers, designs, manufactures and sells specialty piping systems and leak detection systems. Specialty piping systems include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids and petroleum products, and the coating and insulation of oil and gas gathering and transmission pipelines. It operates in the United States, Canada, Middle East, Europe, India and other countries.

Share on Social Networks: